ClariVest Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

ClariVest Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,454	Closed	-$281K	–	844
2020 Q3	$281K	Sell	2,454 -100	-4%	-$10.8K	0.01%	424
2020 Q2	$287K	Hold	2,554	–	–	0.01%	491
2020 Q1	$229K	Sell	2,554 -200	-7%	-$19.6K	0.01%	474
2019 Q4	$298K	Buy	+2,754	New	+$295K	0.01%	453
2014 Q4	–	Sell	-10	Closed	-$2K	–	631
2014 Q3	$2K	Hold	10	–	–	﹤0.01%	522
2014 Q2	$2K	Hold	10	–	–	﹤0.01%	525
2014 Q1	$2K	Hold	10	–	–	﹤0.01%	543
2013 Q4	$1K	Hold	10	–	–	﹤0.01%	583
2013 Q3	$1K	Hold	10	–	–	﹤0.01%	545
2013 Q2	$1K	Buy	+10	New	+$964	﹤0.01%	522

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

ClariVest Asset Management's ALXN Position: Q4 2020 in Review

ClariVest Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 2,454 shares — an estimated $281K sold.

ClariVest Asset Management first reported a position in ALXN in Q2 2013 and held it in 10 quarters. The position peaked at $298K in Q4 2019. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

ClariVest Asset Management reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
ClariVest Asset Management sold 2,454 Alexion Pharmaceuticals shares in Q4 2020, an estimated $281K.
ClariVest Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
ClariVest Asset Management's Alexion Pharmaceuticals position peaked at $298K in Q4 2019.
827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on ClariVest Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.